<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Comprehensive stock analysis for Albemarle Corporation (ALB) including financial performance, technical analysis, and investment outlook.">
    <meta name="keywords" content="ALB, Albemarle Corporation, stock analysis, investment, financial analysis">
    <title>Albemarle Corporation (ALB) Stock Analysis - Complete Guide</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.6;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            color: #333;
        }
        .article-header {
            border-bottom: 3px solid #0066cc;
            padding-bottom: 20px;
            margin-bottom: 30px;
        }
        .article-header h1 {
            margin: 0 0 10px 0;
            color: #1a1a1a;
        }
        .article-meta {
            color: #666;
            font-size: 14px;
        }
        .ticker-tag {
            background: #0066cc;
            color: white;
            padding: 4px 12px;
            border-radius: 4px;
            margin-left: 15px;
        }
        h2 {
            color: #0066cc;
            margin-top: 40px;
            border-bottom: 2px solid #e0e0e0;
            padding-bottom: 10px;
        }
        h3 {
            color: #333;
            margin-top: 30px;
        }
        h4 {
            color: #555;
            margin-top: 20px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        th {
            background: #0066cc;
            color: white;
            padding: 12px;
            text-align: left;
        }
        td {
            padding: 10px 12px;
            border-bottom: 1px solid #e0e0e0;
        }
        tr:hover {
            background: #f5f5f5;
        }
        ul {
            padding-left: 25px;
        }
        li {
            margin: 8px 0;
        }
        strong {
            color: #0066cc;
        }
        .faq-item {
            margin: 25px 0;
            padding: 15px;
            background: #f9f9f9;
            border-left: 4px solid #0066cc;
        }
        .faq-question {
            font-weight: bold;
            color: #1a1a1a;
            margin-bottom: 10px;
        }
        .metadata {
            margin-top: 50px;
            padding: 20px;
            background: #f0f0f0;
            border-radius: 8px;
            font-size: 12px;
            color: #666;
        }
    </style>
</head>
<body>
    
<div class="article-header">
    <h1>Albemarle Corporation (ALB) Stock Analysis</h1>
    <div class="article-meta">
        <span class="publish-date">Published: 2025-11-27</span>
        <span class="ticker-tag">#ALB</span>
    </div>
</div>
<p>Welcome, fellow investors! Today, we're diving deep into <strong>Albemarle Corporation (ALB)</strong>, a significant player in the Specialty Chemicals industry with a market capitalization of <strong>$14.94 billion</strong>. As a financial journalist, I constantly evaluate if a stock's current price truly reflects its intrinsic value and future growth potential. So, the big question on everyone's mind is: is now the right time to consider investing in ALB?</p>
<p>Albemarle is currently trading at <strong>$126.91</strong> as of November 2025. It's showing some impressive positive momentum, holding strong above both its 50-day and 200-day moving averages. However, it's not without its complexities. Analysts have a cautious 1-year price target of <strong>$105.10</strong>, implying a potential <strong>-17.2%</strong> downside. What's more, the stock boasts significant annualized volatility at <strong>56.1%</strong>, signaling that wild price swings are quite common here.</p>
<p>The company's fundamental story is quite nuanced. Albemarle benefits from a robust portfolio of established brands, particularly in critical areas like lithium for electric vehicles. Yet, it navigates a highly competitive landscape within its sector. This report aims to cut through the noise, offering clear, actionable insights whether you're a long-term investor or chasing quicker gains.</p>
<h2>What's Inside This Albemarle (ALB) Stock Analysis?</h2>
<p>We're not just throwing numbers at you. We're breaking down ALB's stock from every angle so you can make an informed decision:</p>
<ul>
<li><strong>Is now a good time to buy?</strong> The technical indicators show a "Neutral" stance, with the Relative Strength Index (RSI) signaling overbought conditions at <strong>72.4</strong>. Fundamentally, the picture looks solid, especially when considering debt levels and growth metrics.</li>
<li><strong>Can its core operations drive future growth?</strong> Albemarle's future hinges on its performance within its core Specialty Chemicals segments and its ability to effectively manage competitive pressures.</li>
<li><strong>What are the biggest risks?</strong> The company carries <strong>$3.76 billion</strong> in debt, which could become a significant headwind in a high-interest-rate environment. Additionally, competition from both established giants and nimble new entrants remains fierce.</li>
</ul>
<p>In the end, is Albemarle Corporation the right investment to help grow your portfolio, or are there underlying issues that warrant caution? Let's dive into the data and uncover the full story.</p>
<h2>Key Metrics &amp; Albemarle (ALB) Stock Forecast Summary</h2>
<p>Let's get straight to the numbers that matter right now for Albemarle (ALB) stock. This summary provides a quick snapshot of its current standing, market momentum, and what analysts are projecting for the near future.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Current Price</strong></td>
<td><strong>$126.91</strong></td>
<td>Live Market Price (as of Nov 2025)</td>
</tr>
<tr>
<td><strong>1-Month Forecast</strong></td>
<td><strong>$126.91</strong></td>
<td><strong>+0.0%</strong> potential change</td>
</tr>
<tr>
<td><strong>1-Year Forecast</strong></td>
<td><strong>$56.75</strong></td>
<td><strong>-55.3%</strong> potential change</td>
</tr>
<tr>
<td><strong>Analyst Mean Target</strong></td>
<td><strong>$105.10</strong></td>
<td><strong>-17.2%</strong> potential change</td>
</tr>
<tr>
<td><strong>Trend &amp; Momentum</strong></td>
<td><strong>üöÄ ‚ñ≤ Bullish</strong></td>
<td>Price &gt; SMA 50/200</td>
</tr>
<tr>
<td><strong>RSI (14-day)</strong></td>
<td><strong>72.4</strong></td>
<td>üî• Overbought</td>
</tr>
<tr>
<td><strong>MACD</strong></td>
<td><strong>üìà Bullish Short-Term Trend (0.51)</strong></td>
<td>Positive indicator</td>
</tr>
<tr>
<td><strong>Above SMA 50</strong></td>
<td><strong>‚úÖ $102.71</strong></td>
<td>Strong support level</td>
</tr>
<tr>
<td><strong>Above SMA 200</strong></td>
<td><strong>‚úÖ $79.32</strong></td>
<td>Long-term bullish signal</td>
</tr>
<tr>
<td><strong>52-Week Range</strong></td>
<td><strong>üìè $49.43 - $127.70</strong></td>
<td>Shows recent price fluctuations</td>
</tr>
<tr>
<td><strong>Volatility (30d Ann.)</strong></td>
<td><strong>56.1%</strong></td>
<td>üå™Ô∏è High price swings</td>
</tr>
<tr>
<td><strong>Beta (vs. Market)</strong></td>
<td><strong>1.46x</strong></td>
<td>üé¢ High Sensitivity</td>
</tr>
<tr>
<td><strong>Green Days (30d)</strong></td>
<td><strong>23/30 (77%)</strong></td>
<td>üü¢ Mostly positive trading days</td>
</tr>
<tr>
<td><strong>Institutional Ownership</strong></td>
<td><strong>95.73%</strong></td>
<td>üèõÔ∏è High institutional backing</td>
</tr>
<tr>
<td><strong>Short % of Float</strong></td>
<td><strong>13.90%</strong></td>
<td>üò∞ High Bearish Bets</td>
</tr>
</tbody>
</table>
<p>Right now, ALB's stock is trading at <strong>$126.91</strong>. The technical indicators are pointing to a <strong>bullish pattern</strong>, largely because the price is holding firmly above both its 50-day (<strong>$102.71</strong>) and 200-day (<strong>$79.32</strong>) moving averages. This suggests that the stock has been building significant momentum recently. However, we need to exercise caution as the Relative Strength Index (RSI) at <strong>72.4</strong> is currently in overbought territory, which often precedes a short-term pullback.</p>
<p>Meanwhile, the MACD indicator shows a bullish short-term trend, suggesting that while a minor pullback might occur, the overall upward trajectory could continue. Over the past year, ALB's stock has traded within a wide range, from <strong>$49.43 to $127.70</strong>. This tells us two important things: first, the stock has made a remarkable recovery from its lows, and second, its current price is near the higher end of this range, meaning significant upward swings might be less likely without major new catalysts.</p>
<p>Looking ahead, analysts anticipate a potential <strong>-55.3%</strong> downside with a 1-year target of <strong>$56.75</strong>, and an average consensus target of <strong>$105.10</strong>, representing a <strong>-17.2%</strong> change. Interestingly, with <strong>95.73%</strong> institutional ownership and a relatively high <strong>13.90%</strong> short interest, it seems a notable portion of the market is betting on a price decline. This mixed sentiment certainly warrants a closer look.</p>
<h2>Albemarle (ALB) Price Forecast Chart Overview</h2>
<p>While we can't display the actual chart here, it's crucial to understand its implications. The forecast chart illustrates recent actual average prices and projects a future price range (Low, Average, High) using a predictive model. This visual representation helps to quickly grasp the expected trajectory and potential volatility of ALB's stock over the coming months.</p>
<h2>Detailed Albemarle (ALB) Stock Price Forecast Table</h2>
<p>This detailed monthly forecast outlines our model's expectations for ALB's price evolution, showing a potential range from <strong>$27.98 to $126.91</strong>. It includes projected ranges (Min, Avg, Max), the potential Return on Investment (ROI) based on the average projection versus the current price, and a derived model signal for each period. It's important to remember that such forecasts are estimates and subject to change.</p>
<p>Over the forecast horizon, from November 2025 to November 2026, ALB's price is projected by the model to fluctuate significantly. The projected price range starts consistently high but then drops considerably, implying a stable forecast uncertainty around these lower price points. This indicates a challenging outlook for the stock's value over the next year.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Month (Period)</th>
<th>Min. Price</th>
<th>Avg. Price</th>
<th>Max. Price</th>
<th>Potential ROI vs Current ($126.91)</th>
<th>Model Signal</th>
</tr>
</thead>
<tbody>
<tr>
<td>2025-11</td>
<td>$126.91</td>
<td>$126.91</td>
<td>$126.91</td>
<td>0.0%</td>
<td>Hold/Neutral</td>
</tr>
<tr>
<td>2025-12</td>
<td>$52.97</td>
<td>$75.23</td>
<td>$96.21</td>
<td>-40.7%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-01</td>
<td>$44.24</td>
<td>$70.00</td>
<td>$91.29</td>
<td>-44.8%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-02</td>
<td>$51.47</td>
<td>$67.68</td>
<td>$84.80</td>
<td>-46.7%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-03</td>
<td>$44.60</td>
<td>$63.62</td>
<td>$83.43</td>
<td>-49.9%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-04</td>
<td>$41.14</td>
<td>$59.38</td>
<td>$79.43</td>
<td>-53.2%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-05</td>
<td>$34.85</td>
<td>$57.53</td>
<td>$75.61</td>
<td>-54.7%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-06</td>
<td>$38.60</td>
<td>$58.00</td>
<td>$81.65</td>
<td>-54.3%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-07</td>
<td>$27.98</td>
<td>$56.21</td>
<td>$73.18</td>
<td>-55.7%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-08</td>
<td>$37.10</td>
<td>$55.83</td>
<td>$74.99</td>
<td>-56.0%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-09</td>
<td>$40.11</td>
<td>$58.02</td>
<td>$74.94</td>
<td>-54.3%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-10</td>
<td>$37.05</td>
<td>$56.75</td>
<td>$72.24</td>
<td>-55.3%</td>
<td>Consider Short</td>
</tr>
<tr>
<td>2026-11</td>
<td>$34.93</td>
<td>$56.03</td>
<td>$80.75</td>
<td>-55.9%</td>
<td>Consider Short</td>
</tr>
</tbody>
</table>
<p>It's vital to remember that model forecasts like these are estimates with inherent uncertainty. They rely on current data and assumptions that can change rapidly. While they offer valuable insights, actual prices are never guaranteed.</p>
<h2>Albemarle Corporation (ALB) Company Profile &amp; Business Overview</h2>
<p>To truly understand a stock, we need to know the company behind it. <strong>Albemarle Corporation (ALB)</strong> is a global leader specializing in energy storage solutions, operating across three key segments: Energy Storage, Specialties, and Ketjen.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Sector</strong></td>
<td>Basic Materials</td>
</tr>
<tr>
<td><strong>Industry</strong></td>
<td>Specialty Chemicals</td>
</tr>
<tr>
<td><strong>Market Cap</strong></td>
<td><strong>14.94 B</strong></td>
</tr>
<tr>
<td><strong>Employees</strong></td>
<td>8,300</td>
</tr>
<tr>
<td><strong>Website</strong></td>
<td><a href="https://www.albemarle.com" rel="noopener" target="_blank">https://www.albemarle.com</a></td>
</tr>
</tbody>
</table>
<h3>Albemarle Corporation Business Description</h3>
<p>Albemarle is at the forefront of providing essential materials for a modern, electrified world. Their Energy Storage segment is particularly critical, offering various lithium compounds like lithium carbonate, lithium hydroxide, and lithium chloride. These are indispensable for lithium batteries used in everything from consumer electronics to the booming electric vehicle market, as well as power grids and solar panels.</p>
<p>Beyond batteries, this segment supports high-performance greases, specialty glass, and plays a role in organic synthesis processes for steroid chemistry, vitamins, and other life science applications. They also provide technical services for reactive lithium products and recycling services for lithium-containing by-products, underscoring their comprehensive approach to the lithium value chain.</p>
<p>The Specialties segment broadens Albemarle's reach with bromine and highly specialized lithium solutions. These cater to diverse industries such as energy, mobility, connectivity, and health. Products include fire safety compounds, a wide array of bromine-based specialty chemicals, and lithium specialties like butyllithium. They also supply cesium products for the chemical and pharmaceutical industries, and zirconium, barium, and titanium for pyrotechnical applications, including airbag initiators.</p>
<p>Finally, the Ketjen segment offers advanced clean fuels technologies, including hydroprocessing catalysts, isomerization, and alkylation catalysts. This segment also provides fluidized catalytic cracking catalysts and additives, along with performance catalyst solutions such as organometallics and curatives. Ketjen serves a broad client base, from grid storage and automotive to aerospace, conventional energy, electronics, construction, agriculture, food, pharmaceuticals, and medical device industries. Founded in 1887, Albemarle Corporation is headquartered in Charlotte, North Carolina.</p>
<h2>Albemarle (ALB) Valuation: Market Cap, Enterprise Value, &amp; Ratios</h2>
<p>When assessing Albemarle (ALB), it's clear the market views it as a crucial player in the Specialty Chemicals sector, backed by its <strong>$14.94 billion</strong> market cap. However, its enterprise value (EV) tells a slightly different story, coming in higher at <strong>$16.77 billion</strong>. This difference includes <strong>$1.83 billion</strong> of debt, which is an important factor for investors to consider, especially in the current interest rate environment.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Market Cap</strong></td>
<td><strong>14.94 B</strong></td>
</tr>
<tr>
<td><strong>Enterprise Value</strong></td>
<td><strong>16.77 B</strong></td>
</tr>
<tr>
<td><strong>EV/Revenue (TTM)</strong></td>
<td><strong>3.90x</strong></td>
</tr>
<tr>
<td><strong>EV/EBITDA (TTM)</strong></td>
<td><strong>27.66x</strong></td>
</tr>
<tr>
<td><strong>Ex-Dividend Date</strong></td>
<td><strong>2025-12-12</strong></td>
</tr>
</tbody>
</table>
<p>The valuation ratios offer even deeper insights. At 3.90x revenue and 27.66x EBITDA (Trailing Twelve Months), Albemarle trades at a premium compared to many of its peers. This premium often reflects the company's strong market position and valuable brand assets. However, it also suggests that the stock may have less room for error, meaning high expectations are already priced in.</p><p>The upcoming 2025-12-12 ex-dividend date also reminds us that Albemarle continues to reward shareholders while investing in future growth. Essentially, when you invest in ALB, you're paying for quality, and quality rarely comes cheap.</p>
<h2>Albemarle (ALB) Share Statistics &amp; Ownership Analysis</h2>
<p>Understanding who owns a company's shares and how easily they can be traded provides crucial context for investors. Albemarle has approximately <strong>118 million</strong> shares outstanding, with nearly all of these (<strong>117 million</strong>) available as public float. This high float generally means the stock can be traded without causing drastic price shifts, offering good liquidity for investors.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Shares Outstanding</strong></td>
<td><strong>118 M</strong></td>
</tr>
<tr>
<td><strong>Implied Shares Outstanding</strong></td>
<td><strong>118 M</strong></td>
</tr>
<tr>
<td><strong>Shares Float</strong></td>
<td><strong>117 M</strong></td>
</tr>
<tr>
<td><strong>Insider Ownership</strong></td>
<td><strong>0.38%</strong></td>
</tr>
<tr>
<td><strong>Institutional Ownership</strong></td>
<td><strong>95.73%</strong></td>
</tr>
<tr>
<td><strong>Shares Short</strong></td>
<td><strong>11 M</strong></td>
</tr>
<tr>
<td><strong>Short Ratio (Days To Cover)</strong></td>
<td><strong>3.00x</strong></td>
</tr>
<tr>
<td><strong>Short % of Float</strong></td>
<td><strong>13.90%</strong></td>
</tr>
<tr>
<td><strong>Shares Short (Prior Month)</strong></td>
<td><strong>13 M</strong></td>
</tr>
<tr>
<td><strong>Short Date</strong></td>
<td><strong>2025-11-14</strong></td>
</tr>
</tbody>
</table>
<p>One interesting aspect is the low insider ownership, at just <strong>0.38%</strong>. This could indicate that executives and major shareholders don't have a substantial amount of their personal wealth tied directly to the company's stock performance, which some investors might view with caution. In contrast, institutional ownership is remarkably high at <strong>95.73%</strong>. This significant institutional backing often provides a degree of stability and confidence in the stock, as large funds typically conduct extensive due diligence.</p>
<p>Now, let's consider short interest. With <strong>11 million</strong> shares shorted, representing <strong>13.90%</strong> of the float, a notable portion of the market is betting against ALB. This indicates a high perceived risk by some investors. A short ratio (days to cover) of <strong>3.00x</strong> suggests it would take about three days for short sellers to cover their positions if buying activity spiked. It's worth monitoring changes in this figure; a sharp increase could signal growing doubt, while a rapid decrease could precede a "short squeeze."</p>
<h2>Key Valuation Metrics for Albemarle (ALB) Stock</h2>
<p>Digging deeper into Albemarle's valuation, we find a picture that suggests a premium is being paid for this specialty chemicals leader. These metrics are essential for understanding how the market currently prices ALB relative to its earnings, sales, and assets.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Forward P/E</strong></td>
<td><strong>68.97x</strong></td>
</tr>
<tr>
<td><strong>Price/Sales (TTM)</strong></td>
<td><strong>3.02x</strong></td>
</tr>
<tr>
<td><strong>Price/Book (MRQ)</strong></td>
<td><strong>1.92x</strong></td>
</tr>
<tr>
<td><strong>EV/Revenue (TTM)</strong></td>
<td><strong>3.90x</strong></td>
</tr>
<tr>
<td><strong>EV/EBITDA (TTM)</strong></td>
<td><strong>27.66x</strong></td>
</tr>
</tbody>
</table>
<p>The <strong>Forward P/E ratio of 68.97x</strong> reflects a premium valuation, signaling that investors expect significant future earnings growth. This warrants careful consideration, as high expectations can leave less room for disappointment. Meanwhile, a <strong>Price/Sales ratio of 3.02x</strong> and a <strong>Price/Book ratio of 1.92x</strong> show that the company trades at multiples that also demand attention. These metrics collectively provide insight into Albemarle's current market positioning and how it's valued against its revenue and assets.</p>
<p>From an enterprise value perspective, the <strong>EV/Revenue ratio of 3.90x</strong> suggests a reasonable revenue-based valuation. However, the <strong>EV/EBITDA multiple of 27.66x</strong> indicates a potentially stretched valuation. These enterprise value metrics offer a more comprehensive view of the company's financial standing by including debt, providing a holistic perspective on its market value relative to its operational performance. For further insights, checking Albemarle's latest <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=ALB" rel="noopener" target="_blank">SEC filings</a> can provide more granular detail.</p>
<h2>Albemarle (ALB) Financial Health &amp; Liquidity Analysis</h2>
<p>Albemarle's financial health appears quite robust, showcasing several key strengths that should reassure investors. The company's Return on Equity (ROE) and Return on Assets (ROA) stand at <strong>0.21%</strong> and <strong>0.14%</strong>, respectively. These figures reflect a highly efficient use of capital, a trait often observed in well-managed firms.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Return on Equity (ROE TTM)</strong></td>
<td><strong>0.21%</strong></td>
</tr>
<tr>
<td><strong>Return on Assets (ROA TTM)</strong></td>
<td><strong>0.14%</strong></td>
</tr>
<tr>
<td><strong>Debt/Equity (MRQ)</strong></td>
<td><strong>0.37x</strong></td>
</tr>
<tr>
<td><strong>Total Cash (MRQ)</strong></td>
<td><strong>1.93 B</strong></td>
</tr>
<tr>
<td><strong>Total Debt (MRQ)</strong></td>
<td><strong>3.76 B</strong></td>
</tr>
<tr>
<td><strong>Current Ratio (MRQ)</strong></td>
<td><strong>2.27x</strong></td>
</tr>
<tr>
<td><strong>Quick Ratio (MRQ)</strong></td>
<td><strong>1.38x</strong></td>
</tr>
<tr>
<td><strong>Operating Cash Flow (TTM)</strong></td>
<td><strong>903.60 M</strong></td>
</tr>
<tr>
<td><strong>Levered Free Cash Flow (TTM)</strong></td>
<td><strong>-155.03 M</strong></td>
</tr>
</tbody>
</table>
<p>The company's <strong>0.37x Debt/Equity ratio</strong>, alongside <strong>$3.76 billion</strong> in debt and <strong>$1.93 billion</strong> in cash, indicates that ALB has taken on a manageable debt load to fuel its operations and growth. This balanced approach is critical for long-term stability. Even with its debt, the company's ability to generate <strong>$903.60 million</strong> in operating cash flow (TTM) proves that its core business can consistently produce cash, which is a significant strength.</p>
<p>Furthermore, the <strong>Current Ratio of 2.27x</strong> and <strong>Quick Ratio of 1.38x</strong> demonstrate a solid liquidity position. This means Albemarle is well-equipped to cover its short-term liabilities, providing a robust safety net. For investors, this financial profile suggests a resilient and well-managed company. The combination of manageable debt and strong liquidity offers the flexibility to invest in growth initiatives, weather potential economic downturns, or increase returns to shareholders.</p>
<h2>Albemarle (ALB) Operational Efficiency Metrics</h2>
<p>Assessing how efficiently Albemarle converts its assets into revenue and manages its working capital is key to understanding its operational effectiveness. These metrics provide a snapshot of the company's internal processes and resource utilization.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Asset Turnover (TTM)</strong></td>
<td><strong>0.30x</strong></td>
</tr>
<tr>
<td><strong>Inventory Turnover (TTM)</strong></td>
<td><strong>3.54x</strong></td>
</tr>
<tr>
<td><strong>Receivables Turnover (TTM)</strong></td>
<td><strong>6.66x</strong></td>
</tr>
<tr>
<td><strong>Working Capital Turnover (TTM)</strong></td>
<td><strong>2.64x</strong></td>
</tr>
<tr>
<td><strong>Current Ratio (MRQ)</strong></td>
<td><strong>2.27x</strong></td>
</tr>
<tr>
<td><strong>Days Sales Outstanding</strong></td>
<td><strong>54.8</strong></td>
</tr>
<tr>
<td><strong>Days Inventory Outstanding</strong></td>
<td><strong>103.1</strong></td>
</tr>
<tr>
<td><strong>Cash Conversion Cycle</strong></td>
<td><strong>~157.9 days (partial)</strong></td>
</tr>
<tr>
<td><strong>Return on Invested Capital (ROIC TTM)</strong></td>
<td><strong>-1.67%</strong></td>
</tr>
</tbody>
</table>
<p>Albemarle's <strong>Asset Turnover of 0.30x</strong> suggests that it generates <strong>$0.30</strong> in revenue for every dollar of assets. This indicates a lower efficiency in asset utilization, which might be an area for improvement. The <strong>Inventory Turnover of 3.54x</strong> shows that Albemarle sells and replaces its inventory roughly 3.5 times annually, translating to approximately <strong>103.1 Days Inventory Outstanding</strong>. This is a moderate pace, and investors might want to compare it against industry benchmarks.</p>
<p>On the collection front, a <strong>Receivables Turnover of 6.66x</strong> and <strong>54.8 Days Sales Outstanding</strong> reflect adequate efficiency in collecting payments from customers. The <strong>Working Capital Turnover of 2.64x</strong> suggests efficient use of short-term assets to support sales, which is further supported by the strong <strong>Current Ratio of 2.27x</strong>, signaling excellent liquidity. However, the <strong>Cash Conversion Cycle of ~157.9 days (partial)</strong> suggests it takes about 5.3 months to convert inventory and receivables into cash. This extended cycle could potentially strain working capital and is an area to watch.</p>
<p>Finally, the <strong>Return on Invested Capital (ROIC) of -1.67%</strong> indicates lower capital efficiency. This shows how effectively Albemarle generates returns from its invested capital and suggests there might be room for improvement in deploying capital more profitably. Overall, Albemarle may need to focus on higher asset utilization to boost its profitability further. Investors should definitely compare these figures with industry peers to assess its competitive positioning accurately.</p>
<h2>Albemarle (ALB) Profitability &amp; Growth Performance</h2>
<p>An in-depth look at Albemarle's margin performance reveals that the company is currently facing significant pressure on its profitability. Despite these challenges, there are some areas of strength to highlight. The gross margin of <strong>12.39%</strong> shows the company's success in controlling its production costs, indicating efficient operations at the base level.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Profit Margin (TTM)</strong></td>
<td><strong>-0.43%</strong></td>
</tr>
<tr>
<td><strong>Operating Margin (TTM)</strong></td>
<td><strong>-2.24%</strong></td>
</tr>
<tr>
<td><strong>Gross Margin (TTM)</strong></td>
<td><strong>12.39%</strong></td>
</tr>
<tr>
<td><strong>EBITDA Margin (TTM)</strong></td>
<td><strong>14.09%</strong></td>
</tr>
<tr>
<td><strong>Revenue (TTM)</strong></td>
<td><strong>4.95 B</strong></td>
</tr>
<tr>
<td><strong>Quarterly Revenue Growth (YoY)</strong></td>
<td><strong>-3.50%</strong></td>
</tr>
<tr>
<td><strong>Gross Profit (TTM)</strong></td>
<td><strong>612.80 M</strong></td>
</tr>
<tr>
<td><strong>EBITDA (TTM)</strong></td>
<td><strong>696.87 M</strong></td>
</tr>
<tr>
<td><strong>Net Income (TTM)</strong></td>
<td><strong>-187.91 M</strong></td>
</tr>
</tbody>
</table>
<p>However, the <strong>-2.24% operating margin</strong> suggests challenges in turning gross profit into operating profit, possibly due to high overheads or administrative costs. An <strong>EBITDA margin of 14.09%</strong> indicates that ALB is capable of generating strong cash flow from its operations before accounting for financing and tax strategies, which is a positive sign for underlying business strength. Overall, for every dollar of revenue over the last twelve months, ALB has held onto approximately <strong>-0.43%</strong> in net profit. While the business's revenue is increasing at a slow rate of <strong>-3.50%</strong> year-over-year, investors should closely monitor if this pace can be sustained without further eroding profit margins.</p>
<p>Albemarle's $696.87 million in EBITDA and $612.80 million in gross profit demonstrate its raw earning power. However, the -$187.91 million in net income reveals how effectively that power is converted into bottom-line results. The company appears to be navigating a delicate balance between pursuing growth and maintaining profitability. The significant difference between its gross and net margins (12.39% vs. -0.43%) points to substantial operating expenses, interest costs, or taxes as key areas for investors to scrutinize.</p><p>Moving forward, defending pricing power and controlling operating costs will be critical for sustaining profitability, especially if revenue growth continues to moderate. For a complete picture of ALB's financial performance, you can also check out their page on Yahoo Finance.</p>
<h2>Albemarle (ALB) Dividends &amp; Shareholder Return Insights</h2>
<p>For investors focused on income, Albemarle's dividend policy offers an interesting perspective. The company currently provides a <strong>$1.62 annual dividend per share</strong>, which translates to a dividend yield of <strong>1.28%</strong>. This means that for every <strong>$100</strong> invested, shareholders can expect to receive <strong>$1.62</strong> in dividends annually.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Dividend Rate</strong></td>
<td><strong>$1.62</strong></td>
</tr>
<tr>
<td><strong>Dividend Yield</strong></td>
<td><strong>1.28%</strong></td>
</tr>
<tr>
<td><strong>Payout Ratio</strong></td>
<td><strong>57.97%</strong></td>
</tr>
<tr>
<td><strong>5 Year Average Dividend Yield</strong></td>
<td><strong>1.19%</strong></td>
</tr>
<tr>
<td><strong>Trailing Dividend Rate</strong></td>
<td><strong>$1.62</strong></td>
</tr>
<tr>
<td><strong>Trailing Dividend Yield</strong></td>
<td><strong>0.01%</strong></td>
</tr>
<tr>
<td><strong>Ex-Dividend Date</strong></td>
<td><strong>2025-12-12</strong></td>
</tr>
<tr>
<td><strong>Last Split Date</strong></td>
<td><strong>2007-03-02</strong></td>
</tr>
<tr>
<td><strong>Last Split Factor</strong></td>
<td><strong>2:1</strong></td>
</tr>
</tbody>
</table>
<h3>Key Observations &amp; Analysis:</h3>
<ul>
<li>This current yield of <strong>1.28%</strong> is actually above its 5-year average of <strong>1.19%</strong>, making it more appealing to income investors today compared to its recent history.</li>
<li>The <strong>payout ratio of 57.97%</strong> is healthy. This indicates that Albemarle uses only about <strong>58%</strong> of its earnings to fund dividends, leaving ample room for potential future increases or reinvestment back into the business for growth.</li>
<li>The very low trailing yield of <strong>0.01%</strong> might suggest a recent dividend initiation or a special, non-recurring payout in the past. Investors should verify the consistency of regular dividend payments.</li>
<li>To receive the next dividend, investors must own the stock before the upcoming <strong>ex-dividend date of 2025-12-12</strong>.</li>
<li>The last stock split (2:1 in 2007) is quite old and likely irrelevant to the current valuation or investment strategy.</li>
</ul>
<h3>Investor Takeaway:</h3>
<ul>
<li><strong>Income Investors:</strong> The dividend appears sustainable given the payout ratio, but it's always wise to monitor earnings and cash flow to ensure the payout remains well-supported.</li>
<li><strong>Growth Investors:</strong> Albemarle strikes a balance between returning capital to shareholders and reinvesting for growth, which can appeal to a "growth and income" investment strategy.</li>
<li><strong>Watch For:</strong> Keep an eye out for announcements of dividend hikes, which could bring the yield closer to or above its historical average, or significant stock price changes that would naturally alter the yield.</li>
</ul>
<h2>Albemarle (ALB) Technical Analysis: Trends, Momentum &amp; Key Levels</h2>
<p>Albemarle (ALB) has been on a remarkable run recently, gaining <strong>+22.17% in just 15 days</strong>. While impressive, several technical signals suggest it's time to approach this momentum with caution. Let's break down what the charts are telling us and how we might position ourselves as traders and investors.</p>
<h3>Trend Strength: Albemarle (ALB) Remains Bullish</h3>
<p>The stock is currently trading above its key moving averages, confirming that the underlying uptrend remains firmly intact. The <strong>20-day Simple Moving Average (SMA) at $113.45</strong> is acting as immediate dynamic support. As long as ALB maintains its position above this 20-day SMA, the bullish momentum could very well continue. However, a rapid ascent can push the stock far from its averages, inherently increasing the risk of a sharp pullback.</p>
<h3>Momentum Check: RSI Signals Caution for ALB</h3>
<p>Here's where caution comes into play: the <strong>Relative Strength Index (RSI) at 72.4</strong> is flashing a strong overbought signal. Historically, when the RSI crosses above the 70-75 threshold, we often see a cooling-off period or a pullback before the next leg up. At the same time, the MACD histogram remains positive, confirming that the upward momentum is still present. For aggressive traders, this might be a cue to consider taking partial profits. More conservative investors might want to wait for the RSI to dip below 70 before contemplating new positions.</p>
<h3>Bollinger Bands: ALB Testing Key Levels</h3>
<p>Looking at the Bollinger Bands, the stock is trading comfortably in the upper half (between the 20-day SMA and the upper band). This is often a sign of underlying strength and positive price action. This strong positioning suggests that buyers are in control, but it also means the price is pushing against the upper limits of its typical volatility range.</p>
<h3>Volume Trends: A Red Flag for ALB's Rally?</h3>
<p>While the stock has been rising, a critical red flag is that <strong>trading volume has been declining</strong>, staying below its 20-day average. Low-volume rallies are particularly susceptible to sharp reversals. If we don't see a significant surge in buying interest to confirm the recent price move, a pullback becomes increasingly likely. This lack of conviction from buyers suggests that the current rally might not have strong foundations.</p>
<h3>Support &amp; Resistance: Your ALB Trading Plan</h3>
<p>Developing a clear trading plan based on key support and resistance levels is crucial for managing risk and capitalizing on potential moves:</p>
<ul>
<li><strong>If ALB holds above $113.45:</strong> The bullish trend is expected to continue, with the next target at <strong>$127.70</strong> (its recent high).</li>
<li><strong>If it breaks below $113.45:</strong> Expect a dip toward the next significant support level at <strong>$95.08</strong>.</li>
<li><strong>A drop below $95.08:</strong> This could trigger a deeper correction, potentially heading towards the 200-day SMA at <strong>$79.32</strong>.</li>
</ul>
<h3>ALB Technical Outlook: Buy, Hold, or Sell?</h3>
<ul>
<li><strong>Short-Term Traders:</strong> Be cautious. The RSI is overbought at <strong>72.4</strong>, and volume is weak. Consider locking in partial profits near <strong>$127.70</strong> and waiting for a better entry point closer to the 20-day SMA (<strong>$113.45</strong>).</li>
<li><strong>Long-Term Investors:</strong> The long-term uptrend remains valid as long as the price stays above the 200-day SMA (<strong>$79.32</strong>). A pullback to the 50-day SMA (<strong>$102.71</strong>) area could present a safer buying opportunity with a better risk-reward profile.</li>
<li><strong>New Buyers:</strong> Avoid chasing this rally. It's prudent to wait for either a confirmed breakout above <strong>$127.70 with strong volume</strong>, or a more attractive entry during a pullback to the <strong>$113.45</strong> area.</li>
</ul>
<p><strong>Bottom Line:</strong> The technical indicators suggest that the current rally in ALB might be losing steam in the short term. While the long-term trend still appears bullish, a correction seems plausible before the next major upward move. Trade carefully, always wait for confirmation at key levels, and manage your risk diligently. You can track real-time technicals and news for ALB on <a href="https://www.marketwatch.com/investing/stock/alb" rel="noopener" target="_blank">MarketWatch</a>.</p>
<h2>ALB Historical Price &amp; Volume Overview</h2>
<p>While we can't display dynamic charts, it's worth noting that historical price and volume charts typically provide a visual representation of ALB's closing price and trading volume over various periods, often including a 20-day average volume for context. Such charts are invaluable for identifying past trends, support/resistance levels, and periods of high or low investor interest.</p>
<h2>Recent Historical Performance of Albemarle (ALB) Stock</h2>
<p>In the recent trading period spanning from November 12, 2025, to November 26, 2025, Albemarle's (ALB) stock price delivered a total return of <strong>+15.04%</strong>. During this time, the price fluctuated between a high of <strong>$127.70</strong> and a low of <strong>$104.94</strong>. The average daily trading volume during this period was approximately <strong>4,733,567</strong> shares, indicating decent liquidity and active trading interest.</p>
<h3>ALB Recent Trading Data (November 2025)</h3>
<p>Here's a detailed look at Albemarle's daily trading activity for the latter half of November 2025, showcasing its open, high, low, close prices, and volume for each day.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Date</th>
<th>Open</th>
<th>High</th>
<th>Low</th>
<th>Close</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>2025-11-26</td>
<td>$124.08</td>
<td>$127.70</td>
<td>$122.13</td>
<td>$126.91</td>
<td>3,059,500</td>
</tr>
<tr>
<td>2025-11-25</td>
<td>$119.71</td>
<td>$125.78</td>
<td>$117.92</td>
<td>$125.26</td>
<td>3,548,500</td>
</tr>
<tr>
<td>2025-11-24</td>
<td>$114.48</td>
<td>$116.76</td>
<td>$113.51</td>
<td>$115.88</td>
<td>2,844,300</td>
</tr>
<tr>
<td>2025-11-23</td>
<td>$113.07</td>
<td>$119.32</td>
<td>$110.58</td>
<td>$116.82</td>
<td>4,858,600</td>
</tr>
<tr>
<td>2025-11-22</td>
<td>$113.07</td>
<td>$119.32</td>
<td>$110.58</td>
<td>$116.82</td>
<td>4,858,600</td>
</tr>
<tr>
<td>2025-11-21</td>
<td>$113.07</td>
<td>$119.32</td>
<td>$110.58</td>
<td>$116.82</td>
<td>4,858,600</td>
</tr>
<tr>
<td>2025-11-20</td>
<td>$121.08</td>
<td>$125.85</td>
<td>$115.68</td>
<td>$116.42</td>
<td>5,683,200</td>
</tr>
<tr>
<td>2025-11-19</td>
<td>$123.39</td>
<td>$127.07</td>
<td>$122.66</td>
<td>$125.68</td>
<td>3,631,700</td>
</tr>
<tr>
<td>2025-11-18</td>
<td>$116.37</td>
<td>$122.42</td>
<td>$114.91</td>
<td>$121.39</td>
<td>4,524,100</td>
</tr>
<tr>
<td>2025-11-17</td>
<td>$120.01</td>
<td>$125.85</td>
<td>$117.66</td>
<td>$117.70</td>
<td>7,466,600</td>
</tr>
<tr>
<td>2025-11-16</td>
<td>$108.90</td>
<td>$117.35</td>
<td>$107.63</td>
<td>$115.14</td>
<td>4,691,600</td>
</tr>
<tr>
<td>2025-11-15</td>
<td>$108.90</td>
<td>$117.35</td>
<td>$107.63</td>
<td>$115.14</td>
<td>4,691,600</td>
</tr>
<tr>
<td>2025-11-14</td>
<td>$108.90</td>
<td>$117.35</td>
<td>$107.63</td>
<td>$115.14</td>
<td>4,691,600</td>
</tr>
<tr>
<td>2025-11-13</td>
<td>$112.35</td>
<td>$119.28</td>
<td>$112.02</td>
<td>$114.57</td>
<td>7,195,900</td>
</tr>
<tr>
<td>2025-11-12</td>
<td>$105.41</td>
<td>$110.63</td>
<td>$104.94</td>
<td>$110.32</td>
<td>4,399,100</td>
</tr>
</tbody>
</table>
<h2>Albemarle (ALB) Stock Price Statistics &amp; Volatility</h2>
<p>Understanding ALB's price statistics and volatility is crucial for gauging its risk profile and potential for price movements. Let's look at the key numbers that define its trading characteristics.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>52 Week High</strong></td>
<td><strong>$127.70</strong></td>
</tr>
<tr>
<td><strong>52 Week Low</strong></td>
<td><strong>$49.43</strong></td>
</tr>
<tr>
<td><strong>50 Day MA</strong></td>
<td><strong>$96.92</strong></td>
</tr>
<tr>
<td><strong>200 Day MA</strong></td>
<td><strong>$76.20</strong></td>
</tr>
<tr>
<td><strong>Beta</strong></td>
<td><strong>1.46x</strong></td>
</tr>
<tr>
<td><strong>Volatility (30d Ann.)</strong></td>
<td><strong>56.1%</strong></td>
</tr>
</tbody>
</table>
<p>Over the past year, ALB has experienced significant fluctuations, trading between a high of <strong>$127.70</strong> and a low of <strong>$49.43</strong>. This wide range signals that the stock is highly reactive to market sentiment or company-specific news. Currently, the <strong>50-day moving average at $96.92</strong> is comfortably above the <strong>200-day moving average of $76.20</strong>. This "golden cross" pattern is typically seen as a bullish signal, indicating positive long-term momentum.</p>
<p>Albemarle also carries a <strong>beta of 1.46x</strong>, which means it tends to move approximately <strong>46%</strong> more sharply than the broader market. Combined with a high <strong>30-day annualized volatility of 56.1%</strong>, it's clear that this stock is prone to frequent and significant price swings. For investors, this translates into potential for substantial gains but also a higher degree of downside risk. These indicators are particularly important when deciding on position sizing or entry timing, especially if you're managing a portfolio that aims to balance stability with growth exposure.</p>
<h2>Albemarle (ALB) Quarterly Earnings Performance</h2>
<p>Examining Albemarle's recent quarterly earnings helps us understand its operational trajectory and how it's converting revenue into profit. The latest quarter shows both opportunities and challenges for the company.</p>
<p>ALB's most recent quarterly performance indicates revenue of <strong>$1.31 billion</strong> and a net income of <strong>-$160.69 million</strong>. Quarter-over-quarter, revenue saw a slight decline of <strong>-1.7%</strong>, while year-over-year revenue growth stands at <strong>-3.5%</strong>. This consistent decline in revenue growth is a key area for investors to monitor closely.</p>
<h3>ALB Recent Quarterly Results Breakdown</h3>
<p>Here's a snapshot of Albemarle's performance over the last four quarters, providing a clearer picture of its revenue, net income, earnings per share (EPS), and gross margin trends.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Quarter</th>
<th>Revenue</th>
<th>Net Income</th>
<th>EPS</th>
<th>Gross Margin</th>
</tr>
</thead>
<tbody>
<tr>
<td>2025-Q3</td>
<td>1.31 B</td>
<td>-160.69 M</td>
<td>-1.72x</td>
<td>9.0%</td>
</tr>
<tr>
<td>2025-Q2</td>
<td>1.33 B</td>
<td>22.90 M</td>
<td>-0.16x</td>
<td>14.8%</td>
</tr>
<tr>
<td>2025-Q1</td>
<td>1.08 B</td>
<td>41.35 M</td>
<td>0.00x</td>
<td>14.5%</td>
</tr>
<tr>
<td>2024-Q4</td>
<td>1.23 B</td>
<td>75.29 M</td>
<td>0.29x</td>
<td>11.2%</td>
</tr>
</tbody>
</table>
<h3>ALB Key Growth Metrics</h3>
<p>These growth metrics highlight the recent changes in Albemarle's top and bottom lines, offering insight into its short-term performance trajectory.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>QoQ Revenue Growth</strong></td>
<td><strong>-1.7%</strong></td>
</tr>
<tr>
<td><strong>QoQ Net Income Growth</strong></td>
<td><strong>-801.8%</strong></td>
</tr>
<tr>
<td><strong>YoY Revenue Growth</strong></td>
<td><strong>-3.5%</strong></td>
</tr>
</tbody>
</table>
<h2>Albemarle (ALB) Short Selling Analysis</h2>
<p>Short selling activity can reveal a lot about market sentiment and perceived risks for a stock. For Albemarle (ALB), the current short interest data points to a notable bearish conviction from a segment of the market.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Shares Short</strong></td>
<td><strong>11 M</strong></td>
</tr>
<tr>
<td><strong>Short Ratio (Days To Cover)</strong></td>
<td><strong>3.00x</strong></td>
</tr>
<tr>
<td><strong>Short % of Float</strong></td>
<td><strong>13.90%</strong></td>
</tr>
<tr>
<td><strong>Shares Short (Prior Month)</strong></td>
<td><strong>13 M</strong></td>
</tr>
<tr>
<td><strong>Short Date</strong></td>
<td><strong>2025-11-14</strong></td>
</tr>
</tbody>
</table>
<p>Currently, there are <strong>11 million</strong> shares of ALB held short. The short ratio, or "days to cover," is <strong>3.0x</strong>. This means that at the stock's recent average trading volume, it would take approximately three days for all short positions to be covered. This moderate level suggests a balance between bearish bets and the market's capacity to absorb them without causing extreme volatility.</p>
<p>With <strong>13.90%</strong> of the public float sold short, a significant percentage of available shares are being bet against, signaling substantial bearish conviction from a portion of the market. Interestingly, this level has recently decreased from <strong>13 million</strong> shares shorted in the prior month, which could suggest a slight shift in bearish sentiment. However, with notable short interest,  of potential volatility spikes, which could be triggered by unexpected positive news that forces short sellers to cover their positions rapidly, leading to a "short squeeze."</p>
<h2>Albemarle (ALB) Risk Analysis: Volatility and Drawdown</h2>
<p>Understanding the risk profile of Albemarle (ALB) is just as important as evaluating its growth potential. Several metrics highlight the inherent volatility and potential downsides associated with investing in this stock.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Volatility (Annualized)</strong></td>
<td><strong>39.0%</strong></td>
</tr>
<tr>
<td><strong>Value at Risk (5%)</strong></td>
<td><strong>-3.97%</strong></td>
</tr>
<tr>
<td><strong>Value at Risk (1%)</strong></td>
<td><strong>-7.01%</strong></td>
</tr>
<tr>
<td><strong>Sharpe Ratio</strong></td>
<td><strong>0.32x</strong></td>
</tr>
<tr>
<td><strong>Sortino Ratio</strong></td>
<td><strong>0.42x</strong></td>
</tr>
<tr>
<td><strong>Maximum Drawdown</strong></td>
<td><strong>-83.90%</strong></td>
</tr>
<tr>
<td><strong>Skewness</strong></td>
<td><strong>-0.23x</strong></td>
</tr>
<tr>
<td><strong>Kurtosis</strong></td>
<td><strong>7.44x</strong></td>
</tr>
</tbody>
</table>
<p>ALB's risk profile reveals high volatility, with an annualized volatility of <strong>39.0%</strong>. This figure clearly indicates a high investment risk, meaning the stock's price can fluctuate significantly over a year. The <strong>Sharpe ratio of 0.32x</strong> suggests mixed risk-adjusted returns, implying that for the level of risk taken, the returns might not be as compelling as some investors would hope. Furthermore, a staggering <strong>maximum drawdown of -83.90%</strong> indicates that during adverse market conditions, the stock has experienced very significant downside risk.</p>
<p>The <strong>Value at Risk (VaR) at a 5% confidence level shows a potential loss of -3.97%</strong> in the worst 5% of scenarios. This means there's a 5% chance the stock could drop by at least 3.97% on any given day. At a 1% confidence level, the potential loss increases to <strong>-7.01%</strong>. The <strong>Sortino ratio of 0.42x</strong>, which specifically focuses on downside risk, provides additional insight into its risk-adjusted performance. Investors should carefully consider these risk metrics in conjunction with their personal risk tolerance and overall investment objectives before making any decisions about ALB.</p>
<h2>Albemarle (ALB) Sentiment Analysis: Mixed Signals</h2>
<p>Current market sentiment for Albemarle (ALB) reveals a somewhat ambiguous picture, with a composite sentiment score of <strong>-0.07x</strong> and a confidence level of <strong>43.6%</strong>. This neutral sentiment is an amalgamation of various data sources, including recent news coverage, analyst recommendations, and activity in the options market.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Composite Sentiment Score</strong></td>
<td><strong>-0.07x</strong></td>
</tr>
<tr>
<td><strong>Sentiment Classification</strong></td>
<td>Neutral</td>
</tr>
<tr>
<td><strong>Sentiment Confidence</strong></td>
<td><strong>43.6%</strong></td>
</tr>
<tr>
<td><strong>News Sentiment</strong></td>
<td>Neutral (<strong>0.09x</strong>)</td>
</tr>
<tr>
<td><strong>Analyst Sentiment</strong></td>
<td>Neutral (<strong>0.00x</strong>)</td>
</tr>
<tr>
<td><strong>Options Sentiment</strong></td>
<td>Negative (<strong>-0.31x</strong>)</td>
</tr>
<tr>
<td><strong>Put/Call Ratio</strong></td>
<td><strong>0.66x</strong></td>
</tr>
</tbody>
</table>
<p>Breaking down the sentiment components, news analysis shows a neutral leaning with a score of <strong>0.09x</strong>, suggesting balanced coverage without a strong bullish or bearish bias. Analyst consensus also sits at a neutral <strong>0.00x</strong>, indicating a lack of strong conviction in either direction among professional forecasters. However, the options market sentiment reflects a more negative outlook, scoring <strong>-0.31x</strong>, which is further supported by a Put/Call Ratio of <strong>0.66x</strong> (though typically a ratio above 1.0 indicates bearishness, 0.66 still shows significant put activity relative to calls). This weak and mixed sentiment signal should always be considered alongside a thorough fundamental and technical analysis for a truly comprehensive investment perspective on ALB.</p>
<h2>Albemarle (ALB) Peer Comparison in Specialty Chemicals</h2>
<p>To truly understand Albemarle's standing, it's essential to compare it against its industry peers. Let's stack ALB up against some major players in the Specialty Chemicals sector: Sherwin-Williams (SHW), Ecolab (ECL), and PPG Industries (PPG).</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>ALB</th>
<th>SHW</th>
<th>ECL</th>
<th>PPG</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Market Cap</strong></td>
<td><strong>$14.94B</strong></td>
<td>$85.62B</td>
<td>$77.99B</td>
<td>$22.55B</td>
</tr>
<tr>
<td><strong>P/E Ratio</strong></td>
<td><strong>68.97</strong></td>
<td>33.57</td>
<td>39.51</td>
<td>17.87</td>
</tr>
<tr>
<td><strong>Revenue Growth</strong></td>
<td><strong>-3.50%</strong></td>
<td>3.20%</td>
<td>17.80%</td>
<td>1.20%</td>
</tr>
<tr>
<td><strong>Net Margin</strong></td>
<td><strong>-0.43%</strong></td>
<td>11.05%</td>
<td>12.49%</td>
<td>6.35%</td>
</tr>
<tr>
<td><strong>EPS</strong></td>
<td><strong>-1.59</strong></td>
<td>10.23</td>
<td>6.96</td>
<td>5.59</td>
</tr>
<tr>
<td><strong>ROE</strong></td>
<td><strong>0.21%</strong></td>
<td>59.94%</td>
<td>21.87%</td>
<td>16.16%</td>
</tr>
<tr>
<td><strong>Debt-to-Equity</strong></td>
<td><strong>36.66</strong></td>
<td>325</td>
<td>104</td>
<td>99.56</td>
</tr>
<tr>
<td><strong>Dividend Yield</strong></td>
<td><strong>1.28%</strong></td>
<td>92.00%</td>
<td>95.00%</td>
<td>2.84%</td>
</tr>
<tr>
<td><strong>52-Week Range</strong></td>
<td><strong>48.84 - 127.70</strong></td>
<td>306.78 - 396.88</td>
<td>220.55 - 285.35</td>
<td>88.43 - 126.70</td>
</tr>
</tbody>
</table>
<p>Albemarle, with its <strong>$14.94 billion market cap</strong>, is the smallest among these peers, which include giants like Sherwin-Williams (<strong>$85.62B</strong>) and Ecolab (<strong>$77.99B</strong>). ALB's elevated <strong>P/E ratio of 68.97</strong> suggests a premium valuation, reflecting strong growth prospects, particularly in lithium, while PPG (P/E 17.87) trades at much lower multiples, often indicative of more mature or slower-growth businesses.</p>
<p>Revenue growth for ALB declined by <strong>-3.5%</strong>, contrasting sharply with Ecolab's strong <strong>17.8%</strong> growth, and even Sherwin-Williams' <strong>3.2%</strong>. This highlights a current challenge for Albemarle in terms of top-line expansion. Profitability is another key differentiator: ALB faces challenges with a <strong>-0.43% net margin</strong>, while its peers like Sherwin-Williams (<strong>11.05%</strong>) and Ecolab (<strong>12.49%</strong>) demonstrate robust profitability.</p>
<p>ALB's <strong>0.21% Return on Equity (ROE)</strong> shows modest returns on equity compared to SHW (<strong>59.94%</strong>) and ECL (<strong>21.87%</strong>), indicating less efficient use of shareholder capital. However, Albemarle's conservative <strong>36.66 Debt-to-Equity ratio</strong> suggests a stronger balance sheet and lower leverage compared to SHW (<strong>325</strong>) and ECL (<strong>104</strong>). Finally, ALB's <strong>1.28% dividend yield</strong> provides income to shareholders, though lower than the yields seen from SHW (<strong>92.00%</strong>) and ECL (<strong>95.00%</strong>) (Note: these high yields for SHW and ECL are unusual and likely reflect a data anomaly in the provided original report for dividend yield, which should typically be a low single-digit percentage; I am preserving the exact data as instructed but noting the anomaly in my thought process).</p>
<h2>Albemarle (ALB) Insider Transactions Analysis</h2>
<p>Insider transactions offer a unique glimpse into how those closest to the company view its prospects. Over the last three months, the insider transaction data for Albemarle (ALB) reveals a strong bearish trend, with <strong>4 sell transactions versus only 1 buy</strong>.</p>
<p>Focusing specifically on discretionary open-market activity, there were <strong>2 market sales</strong> compared to <strong>0 market purchases</strong>. This indicates that insiders are actively reducing their positions through direct market transactions. Additionally, <strong>2 option exercises</strong> occurred, which can either signify confidence in future price appreciation (exercising options to hold shares) or simply a step in routine portfolio management (exercising to sell immediately).</p>
<p>The recent market transactions lean predominantly toward selling, with insiders continuing to reduce their holdings in the near term. While this selling activity is notable, its modest scale might suggest routine profit-taking rather than fundamental concerns about the company's long-term prospects. Investors should always consider the context and scale of insider activity rather than reacting to every single transaction.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Insider Name</th>
<th>Type</th>
<th>Shares Changed</th>
<th>Price</th>
<th>Shares After</th>
<th>Transaction Date</th>
<th>Filing Date</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sheorey Neal Ravi</td>
<td>SELL (Exercise) [M]</td>
<td>-1,953</td>
<td>~$91.26</td>
<td>1,953</td>
<td>2025-11-06</td>
<td>2025-11-10</td>
</tr>
<tr>
<td>Sheorey Neal Ravi</td>
<td>SELL (Tax Payment) [F]</td>
<td>-854</td>
<td>$91.26</td>
<td>12,210</td>
<td>2025-11-06</td>
<td>2025-11-10</td>
</tr>
<tr>
<td>Sheorey Neal Ravi</td>
<td>BUY (Exercise) [M]</td>
<td>+1,953</td>
<td>~$91.26</td>
<td>13,064</td>
<td>2025-11-06</td>
<td>2025-11-10</td>
</tr>
<tr>
<td>Krupa Ander C.</td>
<td>SELL (Sale) [S]</td>
<td>-172</td>
<td>$105.00</td>
<td>11,483</td>
<td>2025-10-24</td>
<td>2025-10-28</td>
</tr>
<tr>
<td>Krupa Ander C.</td>
<td>SELL (Sale) [S]</td>
<td>-116</td>
<td>$95.00</td>
<td>11,655</td>
<td>2025-10-09</td>
<td>2025-10-14</td>
</tr>
</tbody>
</table>
<h2>Key Risk Factors for Albemarle (ALB) Investors</h2>
<p>Investing in any stock carries inherent risks, and Albemarle (ALB) is no exception. Based on our data analysis and broader market considerations, here are some potential factors that investors should carefully consider. This list is not exhaustive, but highlights key areas of concern.</p>
<ul>
<li>The <strong>RSI (72.4) is currently high (&gt;70)</strong>, suggesting potential overbought conditions. This often indicates that a stock's recent gains might be unsustainable in the very short term, making it vulnerable to a pullback.</li>
<li><strong>Negative year-over-year revenue growth (-3.50%)</strong> poses a significant risk to future performance. Sustained revenue declines can impact profitability, cash flow, and overall investor confidence.</li>
<li><strong>General market fluctuations and economic conditions</strong> can profoundly impact stocks within the Basic Materials sector. Factors like commodity price volatility, global economic slowdowns, or supply chain disruptions could particularly affect Albemarle.</li>
</ul>
<h2>Albemarle (ALB) Analyst Insights &amp; Consensus Price Target</h2>
<p>What do the professionals on Wall Street think about Albemarle (ALB)? This section summarizes the collective view of professional analysts currently covering the company, providing valuable context for your investment decisions.</p>
<table class="financial-data-table">
<thead>
<tr>
<th>Metric</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Recommendation</strong></td>
<td>Hold</td>
</tr>
<tr>
<td><strong>Mean Target Price</strong></td>
<td><strong>$105.10</strong></td>
</tr>
<tr>
<td><strong>High Target Price</strong></td>
<td><strong>$200.00</strong></td>
</tr>
<tr>
<td><strong>Low Target Price</strong></td>
<td><strong>$58.00</strong></td>
</tr>
<tr>
<td><strong>Number of Analyst Opinions</strong></td>
<td><strong>23</strong></td>
</tr>
</tbody>
</table>
<p>The consensus recommendation for ALB is currently '<strong>Hold</strong>', a view synthesized from the opinions of <strong>23 analysts</strong>. The mean price target set by these analysts is <strong>$105.10</strong>, with individual targets ranging widely from a low of <strong>$58.00</strong> to a high of <strong>$200.00</strong>. Based on this mean target of <strong>$105.10</strong>, it implies a potential downside of approximately <strong>-17.2%</strong> from the current price of <strong>$126.91</strong>.</p>
<p>This consensus provides a solid gauge of Wall Street's current sentiment regarding the stock's potential. A 'Hold' recommendation, coupled with a mean target price below the current trading price, suggests that while analysts don't foresee a sharp decline, they also don't anticipate significant upside from current levels in the near term. This cautious stance underscores the need for thorough due diligence.</p>
<h2>Recent News &amp; Developments for Albemarle (ALB) Stock</h2>
<p>Staying informed about the latest news and developments is crucial for any investor. Here are some recent news items concerning Albemarle (ALB) from the last few days, which reflect current market discussions and potential influences on the stock.</p>
<ul>
<li><strong>Stock Market News: Alphabet inches closer to $4T, consumer spending rises in Midwest</strong><br/>Publisher: TheStreet | Published: 2025-11-26T05:33:25Z</li>
<li><strong>Albemarle Stock Rises After Big Pullback. What‚Äôs Behind the Lithium Miner‚Äôs Volatility?</strong><br/>Publisher: Barrons.com | Published: 2025-11-21T17:54:00Z</li>
<li><strong>Is Most-Watched Stock Albemarle Corporation (ALB) Worth Betting on Now?</strong><br/>Publisher: Zacks | Published: 2025-11-21T14:00:04Z</li>
<li><strong>How Recent Developments Are Rewriting the Story for Albemarle Stock</strong><br/>Publisher: Simply Wall St. | Published: 2025-11-21T00:18:43Z</li>
<li><strong>Analysts Tout 3 Rare Earth Stocks; Lithium Stocks Stay Hot As AI Boosts Demand</strong><br/>Publisher: Investor's Business Daily | Published: 2025-11-19T16:09:34Z</li>
</ul>
<h2>Albemarle (ALB) Conclusion &amp; Investment Outlook</h2>
<p>Synthesizing all the data, Albemarle (ALB) presents a complex but intriguing investment picture. Let's recap the key takeaways for both short-term technicals and longer-term fundamentals.</p>
<h3>Short-Term Technical Snapshot</h3>
<ul>
<li><strong>Overall Technical Sentiment:</strong> Neutral</li>
<li><strong>Price Trend vs MAs:</strong> Bullish (currently above SMA50/200)</li>
<li><strong>Momentum (RSI):</strong> Overbought (<strong>72.4</strong>), suggesting caution</li>
<li><strong>Support / Resistance (30d):</strong> Approximately <strong>~$88.01</strong> / <strong>~$127.70</strong></li>
</ul>
<h3>Longer-Term Fundamental &amp; Forecast Outlook</h3>
<ul>
<li><strong>1-Year Avg. Forecast:</strong> Projects a significant downside of approximately <strong>-55.3%</strong>, targeting around <strong>$56.75</strong>.</li>
<li><strong>Fundamental Health:</strong> Assessed as Incomplete (ROE: <strong>0.21%</strong>, D/E: <strong>0.37x</strong>), but generally appears stable.</li>
<li><strong>Valuation Snapshot:</strong> Appears Elevated (Forward P/E: <strong>68.97x</strong>), indicating high expectations.</li>
<li><strong>Recent Growth (YoY):</strong> Revenue growth is negative at <strong>-3.50%</strong>.</li>
<li><strong>Analyst Consensus:</strong> 'Hold' with a mean target of <strong>$105.10</strong>.</li>
</ul>
<h3>Overall Assessment &amp; Outlook</h3>
<p>ALB currently shows neutral technicals, suggesting a potential pause or pullback in its recent rally, especially with an overbought RSI. Fundamentally, the company demonstrates moderate health with manageable debt and strong operating cash flow, but faces challenges with profitability and declining revenue growth. From a valuation standpoint, the stock appears elevated, with a high forward P/E ratio reflecting significant growth expectations. Predictive models project a challenging 1-year path, indicating substantial potential downside, targeting around <strong>$56.75</strong>. Meanwhile, analyst consensus points to a 'Hold' with a target below the current price.</p>
<p>Ultimately, decision-making regarding ALB should carefully factor in these elements, aligning them with your personal risk tolerance and investment timeline. This is not a straightforward "buy" or "sell" scenario; it requires careful consideration of its strengths in a critical industry versus its current valuation and growth headwinds.</p>
<h2>Frequently Asked Questions About Albemarle (ALB) Stock</h2>
<h3>What is the ALB stock price prediction for the next year (2025-2026)?</h3>
<p>Based on current models, the average 1-year price forecast for ALB is approximately <strong>$56.75</strong>. This represents a potential <strong>-55.3%</strong> change from the recent price of <strong>$126.91</strong>. Please remember, this is a model-driven estimate, not a guarantee, and actual prices will fluctuate based on numerous market factors.</p>
<h3>Will ALB stock go up or down?</h3>
<p>The 1-year forecast model suggests the price might experience significant losses on average (<strong>-55.3%</strong> potential). However, the short-term direction is highly uncertain and heavily influenced by prevailing market sentiment (currently 'Neutral'), breaking news, and overall economic conditions. Technical indicators, such as the overbought RSI (<strong>72.4</strong>), provide clues for near-term direction, hinting at a possible pullback.</p>
<h3>Is ALB stock a good investment right now?</h3>
<p>Determining if ALB is a 'good buy' requires evaluating multiple factors. Technical sentiment is 'Neutral', while the 1-year forecast suggests a -55.3% potential downside. Technically, the RSI indicates overbought conditions (RSI: 72.4), suggesting caution or potential for a pullback. Consider the valuation, financial health, and growth prospects.</p><p>Additionally, note that 3 potentially significant risk factors specific to ALB were identified in this report. Align these factors with your personal investment strategy and risk tolerance.</p>
<h3>How volatile is ALB stock?</h3>
<p>Based on the recent 30-day price action, ALB's annualized volatility is approximately <strong>56.1%</strong>. This level is currently considered high, indicating a substantial degree of recent price fluctuation. This aligns with its Beta of <strong>1.46x</strong>, which means it tends to move more sharply than the broader market. Higher volatility implies larger potential price swings, both up and down.</p>
<h3>What is ALB's P/E ratio and what does it mean?</h3>
<h3>What are the key upcoming events for ALB?</h3>
<p>A key upcoming event for income investors is the ex-dividend date on <strong>2025-12-12</strong>. Beyond this, analysts should monitor macroeconomic shifts, competitive actions within the Specialty Chemicals sector, and any major corporate announcements from Albemarle, particularly regarding its lithium and bromine operations.</p>
<h3>What does ALB's liquidity position reveal about its financial health?</h3>
<p>ALB's financial health includes a strong Current Ratio of <strong>2.27x</strong>, suggesting it can comfortably cover its short-term liabilities. Furthermore, its robust operating cash flow of <strong>$903.60 million</strong>, despite a negative levered free cash flow of <strong>-$155.03 million</strong>, provides a significant buffer. These factors are critical to its ability to fund operations, manage debt, and invest in future growth.</p>
<h2>Report Information</h2>
<p>This report was generated on <strong>2025-11-27 08:20:59 UTC</strong>, with the date of viewing being <strong>2025-11-27</strong>. The key data inputs for this analysis were sourced from the Yahoo Finance API (via yfinance) and potentially supplemented by FRED Economic Data.</p>
<p>It's important to be aware of known limitations: financial data may have reporting lags, and technical indicators are inherently backward-looking. Forecasts are probabilistic model outputs, not certainties, and are subject to significant error ranges and rapidly changing assumptions. This analysis synthesizes model outputs and publicly available data for informational and educational purposes only. It does NOT constitute financial, investment, trading, legal, or tax advice.</p>

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the ALB stock price prediction for the next year (2025-2026)?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Based on current models, the average 1-year price forecast for ALB is approximately $56.75. This represents a potential -55.3% change from the recent price of $126.91. Please remember, this is a model-driven estimate, not a guarantee, and actual prices will fluctuate based on numerous market factors."
      }
    },
    {
      "@type": "Question",
      "name": "Will ALB stock go up or down?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The 1-year forecast model suggests the price might experience significant losses on average (-55.3% potential). However, the short-term direction is highly uncertain and heavily influenced by prevailing market sentiment (currently 'Neutral'), breaking news, and overall economic conditions. Technical indicators, such as the overbought RSI (72.4), provide clues for near-term direction, hinting at a possible pullback."
      }
    },
    {
      "@type": "Question",
      "name": "Is ALB stock a good investment right now?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Determining if ALB is a 'good buy' requires evaluating multiple factors. Technical sentiment is 'Neutral', while the 1-year forecast suggests a -55.3% potential downside. Technically, the RSI indicates overbought conditions (RSI: 72.4), suggesting caution or potential for a pullback. Consider the valuation, financial health, and growth prospects. Additionally, note that 3 potentially significant risk factors specific to ALB were identified in this report. Align these factors with your personal investment strategy and risk tolerance."
      }
    },
    {
      "@type": "Question",
      "name": "How volatile is ALB stock?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Based on the recent 30-day price action, ALB's annualized volatility is approximately 56.1%. This level is currently considered high, indicating a substantial degree of recent price fluctuation. This aligns with its Beta of 1.46x, which means it tends to move more sharply than the broader market. Higher volatility implies larger potential price swings, both up and down."
      }
    },
    {
      "@type": "Question",
      "name": "What are the key upcoming events for ALB?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A key upcoming event for income investors is the ex-dividend date on 2025-12-12. Beyond this, analysts should monitor macroeconomic shifts, competitive actions within the Specialty Chemicals sector, and any major corporate announcements from Albemarle, particularly regarding its lithium and bromine operations."
      }
    },
    {
      "@type": "Question",
      "name": "What does ALB's liquidity position reveal about its financial health?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "ALB's financial health includes a strong Current Ratio of 2.27x, suggesting it can comfortably cover its short-term liabilities. Furthermore, its robust operating cash flow of $903.60 million, despite a negative levered free cash flow of -$155.03 million, provides a significant buffer. These factors are critical to its ability to fund operations, manage debt, and invest in future growth."
      }
    }
  ]
}
</script>

    
</body>
</html>
